Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
Castle Biosciences, Inc. has announced that its executive management will present a company overview at the 2026 Jefferies Global Healthcare Conference on June 3, 2026. The company’s innovative tests aim to improve health and guide patient care in dermatologic and gastroenterological diseases.
FRIENDSWOOD, Texas, May 13, 2026 /PRNewswire/ — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the 2026 Jefferies Global…